54. PREDICTION OF ANTIPSYCHOTIC-INDUCED METABOLIC ADVERSE EFFECTS USING MULTIMODAL ARTIFICIAL INTELLIGENCEKhushbu Agarwal, Ayman H. Fanous, Colby Ham et al.|European Neuropsychopharmacology|2024Cited by 1
F81. ELUCIDATING GENETIC AND ENVIRONMENTAL RISK FACTORS FOR ANTIPSYCHOTIC-INDUCED METABOLIC ADVERSE EFFECTS USING ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN THE MILLION VETERAN PROGRAMAyman H. Fanous, Beauty Kolade, Silviu‐Alin Bacanu et al.|European Neuropsychopharmacology|2023Cited by 0